Corbus Pharmaceuticals Holdings Inc 0SZI-GB:London Stock Exchange

RT Quote | Exchange | USD
Last | 09/24/21 BST
UNCH (UNCH)
52 week range
0.95 - 4.28
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close-
  • 52 Week High4.28
  • 52 Week High Date02/11/21
  • 52 Week Low0.95
  • 52 Week Low Date10/26/20

Key Stats

  • Market Cap130.09M
  • Shares Out125.08M
  • 10 Day Average Volume3,842
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-16.83

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close-
  • 52 Week High4.28
  • 52 Week High Date02/11/21
  • 52 Week Low0.95
  • 52 Week Low Date10/26/20
  • Market Cap130.09M
  • Shares Out125.08M
  • 10 Day Average Volume3,842
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-16.83

RATIOS/PROFITABILITY

  • EPS (TTM)-0.81
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Corbus Pharmaceuticals Holdings Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Corbus Pharmaceuticals Holdings, Inc. is a Phase-III, clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company operates through developing and commercializing therapeutics to treat rare life-threatening inflammatory fibrotic diseases segment. The Company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic...
Alan Holmer J.D.
Chairman
Yuval Cohen
Chief Executive Officer
Sean Moran CPA
Chief Financial Officer
Address
500 RIVER RIDGE DRIVE
Norwood, MA
02062
United States